[1] HARREITER J, RODEN M. Diabetes mellitus-definition, klassifikation, diagnose, screening und prevention[J].Wien Klin Wochenschr,2023,135(Suppl 1):7-17.
[2] 中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J].中华肾脏病杂志, 2021, 37(3): 255-304.
[3] ARONOV M, ALLON R, STAVE D,et al. Retinal vascular signs as screening and prognostic factors for chronic kidney disease: a systematic review and Meta-analysis of current evidence[J].J Pers Med,2021,11(7):665.
[4] VENKATESH P,TIBREWAL S,BHOWMIK D,et al.Prevalence of systemic co-morbidities in patients with various grades of diabetic retinopathy[J].Indian J Med Res,2014, 140(1): 77-83.
[5] SAINI D C, KOCHAR A, POONIA R. Clinical correlation of diabetic retinopathy with nephropathy and neuropathy[J].Indian J Ophthalmol,2021,69(11):3364-3368.
[6] CANKURTARAN V,INANC M,TEKIN K,et al.Retinal microcirculation in predicting diabetic nephropathy in type 2 diabetic patients without retinopathy[J].Ophthalmologica,2020,243(4):271-279.
[7] ZHANG B L, CHOU Y Y, ZHAO X Y, et al. Early detection of microvascular impairments with optical coherence tomography angiography in diabetic patients without clinical retinopathy: a meta-analysis[J].Am J Ophthalmol,2021,222:226-237.
[8] SAINI D C,KOCHAR A,POONIA R.Clinical correlation of diabetic retinopathy with nephropathy and neuropathy[J].Indian J Ophthalmol,2021,69(11):3364-3368.
[9] 葛婷,吴超神,黄梦娜,等. 糖尿病肾病和糖尿病视网膜病变应激相关关键基因的生物信息学分析[J].中国中西医结合肾病杂志,2024,25(3):234-237.
[10] PAN D, XU L, GUO M. The role of protein kinase C in diabetic microvascular complications[J].Front Endocrinol (Lausanne),2022,13:973058.
[11] FANG J X, LUO C X, ZHANG D, et al. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study[J].Front Endocrinol (Lausanne),2023,14:1265711.
[12] LIU Y J, WANG W K, ZHANG J T,et al. JAK/STAT signaling in diabetic kidney disease[J].Front Cell Dev Biol,2023,11:1233259.
[13] HONG L B, LIN Y Q, YANG X Y, et al. A Narrative review of STAT proteins in diabetic retinopathy: from mechanisms to therapeutic prospects[J].Ophthalmol Ther,2022,11(6):2005-2026.
[14] FU J, YU M G, LI Q,et al. Insulin's actions on vascular tissues: Physiological effects and pathophysiological contributions to vascular complications of diabetes[J].Mol Metab,2021,52:101236.
[15] ENTEZARI M, HASHEMI D, TAHERIAZAM A,et al. AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation[J].Biomed Pharmacother,2022,146:112563.
[16] YANG J, LIU D W, LIU Z S. Integration of metabolomics and proteomics in exploring the endothelial dysfunction mechanism induced by serum exosomes from diabetic retinopathy and diabetic nephropathy patients[J].Front Endocrinol (Lausanne),2022,13:830466.
[17] FAN X E, XU M H, CHEN X, et al. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease[J].Front Endocrinol (Lausanne),2022,13:1001391.
[18] HUI Z, CHEN Y M, GONG W K,et al. Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis[J].Diab Vasc Dis Res,2022,19(4):14791641221122918.
[19] ONG C J T, WONG M Y Z, CHEONG K X, et al. Optical coherence tomography angiography in retinal vascular disorders[J].Diagnostics (Basel),2023,13(9):1620.
[20] 白子超,李雁杰,曹荣霞,等.糖尿病视网膜病变诊疗的研究现状:基于OCTA[J].眼科新进展,2021,41(9):887-891.
[21] AKIL H, KARST S, HEISLER M,et al.Application of optical coherence tomography angiography in diabetic retinopathy: a comprehensive review[J].Can J Ophthalmol,2019,54(5):519-528.
[22] PRAMIL V,LEVINE E S,WAHEED N K. Macular vessel density in diabetic retinopathy patients: how can we accurately measure and what can it tell us?[J] .Clin Ophthalmol,2021,15:1517-1527.
[23] UCHITOMI D,MURAKAMI T,DODO Y, et al.Disproportion of lamellar capillary non-perfusion in proliferative diabetic retinopathy on optical coherence tomography angiography[J].Br J Ophthalmol,2020,104(6):857-862.
[24] WAHEED N K, ROSEN R B, JIA Y,et al.Optical coherence tomography angiography in diabetic retinopathy[J].Prog Retin Eye Res, 2023,97:101206.
[25] ATTAALLAH H R,MOHAMED A A M,ALI M A.Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography[J].Int Ophthalmol,2019,39(8):1845-1859.
[26] CANKURTARAN V, INANC M, TEKIN K,et al.Retinal Microcirculation in predicting diabetic nephropathy in type 2 diabetic patients without retinopathy[J].Ophthalmologica,2020,243(4):271-279.
[27] 李晓凤,金梅,陆康成.糖尿病肾脏疾病患者黄斑区血流密度的变化分析[J].国际医药卫生导报,2019,25(14):2312-2315.
[28] YAO H Y, LI Z J. Is preclinical diabetic retinopathy in diabetic nephropathy individuals more severe?[J].Front Endocrinol,2023,14:1144257.
[29] 李小豪,张丽,李慧,等.OCTA检测糖尿病肾病患者黄斑区及视盘周围的微循环和结构改变[J].国际眼科杂志,2022,22(2):280-286.
[30] SURAWATSATIEN N, PONGSACHAREONNONT P F, KULVICHIT K,et al.Optical coherence tomography angiography biomarkers in thai patients with diabetic nephropathy: a diabetic eye and kidney diseases (DEK-D) study[J].Transl Vis Sci Technol,2023,12(4):19.
[31] QI Z H, SI Y Y, FENG F,et al.Analysis of retinal and choroidal characteristics in patients with early diabetic retinopathy using WSS-OCTA[J].Front Endocrinol (Lausanne),2023,14:1184717.
[32] 糖尿病肾病多学科诊治与管理共识专家组. 糖尿病肾病多学科诊治与管理专家共识[J].中国临床医生杂志,2020,48(5):522-527.
2025, Vol. 42 
